MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹1,913 Cr | ₹128,186 Cr | ₹1,433 Cr | ₹127 Cr | ₹10,304 Cr |
What is the latest Consolidated Net Profit of MANKIND PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹1,913 Cr |
| Mar2024 | ₹128,186 Cr |
| Mar2023 | ₹1,433 Cr |
| Mar2022 | ₹127 Cr |
| Mar2021 | ₹10,304 Cr |
How is Consolidated Net Profit of MANKIND PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,913 Cr | -98.51 | |
| Mar2024 | ₹128,186 Cr | 8,842.31 | |
| Mar2023 | ₹1,433 Cr | 1,032.80 | |
| Mar2022 | ₹127 Cr | -98.77 | |
| Mar2021 | ₹10,304 Cr | - | |
Compare Consolidated Net Profit of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,068.8 Cr | 5.7% | 0.5% | -24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,131.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,862.0 Cr | 2.9% | 1.8% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,254.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹121,198.0 Cr | 0.2% | -0.2% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,083.0 Cr | 0.9% | 4.8% | -3.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 5.7% |
0.5% |
-24.3% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses